Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy

Advanced prostate cancer remains incurable and is the second leading cause of mortality in men. Immunotherapy based on the adoptive transfer of tumor-infiltrating lymphocytes (TIL) has demonstrated promising clinical results in patients with metastatic melanoma and lately also in other solid tumors....

Descripción completa

Detalles Bibliográficos
Autores principales: Yunger, Sharon, Bar El, Assaf, Zeltzer, Li-at, Fridman, Eddie, Raviv, Gil, Laufer, Menachem, Schachter, Jacob, Markel, Gal, Itzhaki, Orit, Besser, Michal J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844325/
https://www.ncbi.nlm.nih.gov/pubmed/31741775
http://dx.doi.org/10.1080/2162402X.2019.1672494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844325/
https://www.ncbi.nlm.nih.gov/pubmed/31741775
http://dx.doi.org/10.1080/2162402X.2019.1672494

Ejemplares similares